FASN and nasopharyngeal carcinoma: In line with previous studies, elevated FASN expression was significantly associated with T3–T4 stage primary tumors, N1–N3 lymph node metastasis and poor overall survival of NPC patients (Figure 4C; supplementary material, Table S1) 37.